Trial intelligence / Profile preview

Isolagen Therapy in Nasolabial Fold Wrinkles

NCT00649428Phase 3Completed

Sponsor
Castle Creek Biosciences
Start
Oct 2006
Primary completion
Jul 2008
Modality
Bone Marrow HSCs, Peripheral Blood HSCs
Countries
1
01

Overview

A Phase 3 trial of azficel-t in nasolabial fold rhytides, sponsored by Castle Creek Biosciences. Started Oct 2006; status: completed.

02

Drugs

azficel-t
03

Conditions

nasolabial fold rhytides

Beyond the preview

Go deeper on NCT00649428.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00649428.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call